Terms: = Liver cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130
112 results:
1. The clinical relevance of OSM in inflammatory diseases: a comprehensive review.
Wolf CL; Pruett C; Lighter D; Jorcyk CL
Front Immunol; 2023; 14():1239732. PubMed ID: 37841259
[TBL] [Abstract] [Full Text] [Related]
2. Serum Biomarkers of Nociceptive and Neuropathic Pain in Chronic Pancreatitis.
Saloman JL; Li Y; Stello K; Li W; Li S; Phillips AE; Hall K; Fogel EL; Vege SS; Li L; Andersen DK; Fisher WE; Forsmark CE; Hart PA; Pandol SJ; Park WG; Topazian MD; Van Den Eeden SK; Serrano J; Conwell DL; Yadav D;
J Pain; 2023 Dec; 24(12):2199-2210. PubMed ID: 37451493
[TBL] [Abstract] [Full Text] [Related]
3. PROM1-mediated cell signal transduction in cancer stem cells and hepatocytes.
Bahn MS; Ko YG
BMB Rep; 2023 Feb; 56(2):65-70. PubMed ID: 36617467
[TBL] [Abstract] [Full Text] [Related]
4. SRRM1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the JAK/STAT signaling pathway.
Song X; Ma J
Tissue Cell; 2022 Dec; 79():101954. PubMed ID: 36270072
[TBL] [Abstract] [Full Text] [Related]
5. STAT3 is Activated by CTGF-mediated Tumor-stroma Cross Talk to Promote HCC Progression.
Makino Y; Hikita H; Kato S; Sugiyama M; Shigekawa M; Sakamoto T; Sasaki Y; Murai K; Sakane S; Kodama T; Sakamori R; Kobayashi S; Eguchi H; Takemura N; Kokudo N; Yokoi H; Mukoyama M; Tatsumi T; Takehara T
Cell Mol Gastroenterol Hepatol; 2023; 15(1):99-119. PubMed ID: 36210625
[TBL] [Abstract] [Full Text] [Related]
6. Asialoglycoprotein Receptor 1 Functions as a Tumor Suppressor in liver cancer via Inhibition of STAT3.
Zhu X; Song G; Zhang S; Chen J; Hu X; Zhu H; Jia X; Li Z; Song W; Chen J; Jin C; Zhou M; Zhao Y; Xie H; Zheng S; Song P
Cancer Res; 2022 Nov; 82(21):3987-4000. PubMed ID: 36043912
[TBL] [Abstract] [Full Text] [Related]
7. Impaired degradation of YAP1 and il6st by chaperone-mediated autophagy promotes proliferation and migration of normal and hepatocellular carcinoma cells.
Desideri E; Castelli S; Dorard C; Toifl S; Grazi GL; Ciriolo MR; Baccarini M
Autophagy; 2023 Jan; 19(1):152-162. PubMed ID: 35435804
[TBL] [Abstract] [Full Text] [Related]
8. New insights into IL-6 family cytokines in metabolism, hepatology and gastroenterology.
Giraldez MD; Carneros D; Garbers C; Rose-John S; Bustos M
Nat Rev Gastroenterol Hepatol; 2021 Nov; 18(11):787-803. PubMed ID: 34211157
[TBL] [Abstract] [Full Text] [Related]
9. The two facets of gp130 signalling in liver tumorigenesis.
Schmidt-Arras D; Galun E; Rose-John S
Semin Immunopathol; 2021 Aug; 43(4):609-624. PubMed ID: 34047814
[TBL] [Abstract] [Full Text] [Related]
10. NEK9, a novel effector of IL-6/STAT3, regulates metastasis of gastric cancer by targeting ARHGEF2 phosphorylation.
Lu G; Tian S; Sun Y; Dong J; Wang N; Zeng J; Nie Y; Wu K; Han Y; Feng B; Shang Y
Theranostics; 2021; 11(5):2460-2474. PubMed ID: 33500736
[No Abstract] [Full Text] [Related]
11. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
Pozios I; Seel NN; Hering NA; Hartmann L; Liu V; Camaj P; Müller MH; Lee LD; Bruns CJ; Kreis ME; Seeliger H
Cell Oncol (Dordr); 2021 Feb; 44(1):167-177. PubMed ID: 32940862
[TBL] [Abstract] [Full Text] [Related]
12. Fructose stimulated de novo lipogenesis is promoted by inflammation.
Todoric J; Di Caro G; Reibe S; Henstridge DC; Green CR; Vrbanac A; Ceteci F; Conche C; McNulty R; Shalapour S; Taniguchi K; Meikle PJ; Watrous JD; Moranchel R; Najhawan M; Jain M; Liu X; Kisseleva T; Diaz-Meco MT; Moscat J; Knight R; Greten FR; Lau LF; Metallo CM; Febbraio MA; Karin M
Nat Metab; 2020 Oct; 2(10):1034-1045. PubMed ID: 32839596
[TBL] [Abstract] [Full Text] [Related]
13. Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study.
Wang L; Wang W; Rong W; Li Z; Wu F; Liu Y; Zheng Y; Zhang K; Siqin T; Liu M; Chen B; Wu J
BMC Cancer; 2020 Jul; 20(1):614. PubMed ID: 32611327
[TBL] [Abstract] [Full Text] [Related]
14. Uncovering the potential differentially expressed miRNAs as diagnostic biomarkers for hepatocellular carcinoma based on machine learning in The cancer Genome Atlas database.
Zhao X; Dou J; Cao J; Wang Y; Gao Q; Zeng Q; Liu W; Liu B; Cui Z; Teng L; Zhang J; Zhao C
Oncol Rep; 2020 Jun; 43(6):1771-1784. PubMed ID: 32236623
[TBL] [Abstract] [Full Text] [Related]
15. Recurrent chromosomal rearrangements of
Bayard Q; Caruso S; Couchy G; Rebouissou S; Bioulac Sage P; Balabaud C; Paradis V; Sturm N; de Muret A; Guettier C; Bonsang B; Copie C; Letouzé E; Calderaro J; Imbeaud S; Nault JC; Zucman-Rossi J
Gut; 2020 Sep; 69(9):1667-1676. PubMed ID: 31907296
[TBL] [Abstract] [Full Text] [Related]
16. High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation.
Choi GH; Kim GA; Choi J; Han S; Lim YS
Aliment Pharmacol Ther; 2019 Jul; 50(2):215-226. PubMed ID: 31135074
[TBL] [Abstract] [Full Text] [Related]
17. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
[TBL] [Abstract] [Full Text] [Related]
18. Overexpression of interleukin-35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection.
Zhang MX; Gan W; Jing CY; Zheng SS; Zhang J; Shen HJ; Xu X; Lin JJ; Zhang BH; Qiu SJ
Cancer Sci; 2018 Apr; 109(4):1195-1206. PubMed ID: 29446854
[TBL] [Abstract] [Full Text] [Related]
19. MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma.
Zhu W; Wang Y; Zhang D; Yu X; Leng X
Biochem Biophys Res Commun; 2018 Mar; 497(4):963-970. PubMed ID: 29408481
[TBL] [Abstract] [Full Text] [Related]
20. Oncostatin M: Potential Implications for Malignancy and Metabolism.
Stephens JM; Elks CM
Curr Pharm Des; 2017; 23(25):3645-3657. PubMed ID: 28677505
[TBL] [Abstract] [Full Text] [Related]
[Next]
